ScreenYu Gyn® is an in-vitro molecular diagnostic test for gynecological cancer detection and risk assessment. This PCR-based assay identifies clinically relevant biomarkers to support cervical and gynecological pathology diagnosis and patient stratification.
Manufactured by
Jena, Germany
Epitype was initially founded as oncgnostics GmbH in early 2012 as a spin-off from the Department of Gynecology at Jena University Hospital. The foundation for the company’s establishment was laid within the framework of an EU collaborative project (INCA – Infections and Cancer) during research on epigenetic markers in the development of cervical cancer in the Department of Gynecological Molecular Biology (Prof. Dürst). A successful EXIST research transfer project enabled the preparation for founding the company. From the goal of improving early cervical cancer detection, the product GynTect®, a molecular biological test for cervical cancer, emerged and has been on the market since 2015. The developed cancer tests are used in early cancer detection and diagnosis. Since 2025, Epitype GmbH has been further advancing the widespread application of its innovations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
HLB PANAGENE Co., Ltd.
South Korea · 2 relevant products
Access Bio, Inc.
United States · 2 relevant products
Attogen Biomedical(Suzhou)Ltd.Inc
China · 1 relevant product
Acon Biotech (Hangzhou) Co., Ltd.
China · 2 relevant products
Origin Biotechnology Co., Ltd.
Taiwan · 3 relevant products
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 2 relevant products
Bioperfectus
China · 3 relevant products
HOLOGIC
China · 2 relevant products
Xiamen Micalrun Technology Co.,Ltd
China · 1 relevant product
ACON Laboratories, Inc.
United States · 2 relevant products
65 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 106 closest product alternatives
HLB PANAGENE Co., Ltd. · South Korea
A molecular screening test for human papillomavirus detection in clinical samples supporting cervical cancer prevention programs.
Access Bio, Inc. · United States
Molecular test for human papillomavirus detection and screening. PCR-based detection for cervical cancer risk assessment.
Attogen Biomedical(Suzhou)Ltd.Inc · China
Comprehensive cervical cytology detection system for screening intraepithelial neoplasia. Combines immunochemical techniques with molecular markers for cervical disease identification. Designed for routine gynecological screening applications.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
Origin Biotechnology Co., Ltd. · Taiwan
A molecular medicine-based screening test for prenatal diagnosis and prevention of genetic abnormalities. The test provides rapid results to support clinical decision-making in maternal-fetal medicine.
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
In vitro diagnostic test kits specifically developed for gynecological disease detection and diagnosis. These kits support clinical evaluation and patient management in reproductive health.
Bioperfectus · China
Integrated system for HPV detection and cervical cancer screening utilizing nucleic acid extraction and PCR-based analysis. Provides accurate identification of high-risk HPV strains to enable early cervical cancer detection and prevention.
HOLOGIC · China
HPV and cytology-based testing systems for early detection of cervical cancer and precancerous lesions.
Xiamen Micalrun Technology Co.,Ltd · China
Cancer screening kits utilizing microfluidic chip, fluorescent qPCR, and isothermal amplification technologies for precision detection of tumor markers and genetic variants. Designed for early cancer diagnosis, treatment selection, and recurrence monitoring across multiple cancer types. Enables rapid, accurate results for clinical screening and personalized oncology applications.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for prenatal screening and fetal abnormality detection. Assesses risk for genetic and chromosomal disorders.
ACON Laboratories, Inc. · United States
Qualitative screening immunoassay for the detection of cancer markers. Designed for reliable and accessible cancer risk assessment in point-of-care settings.
BD · United States
Products and systems for cervical cancer detection and prevention screening programs. These diagnostic solutions support early detection and improved patient outcomes.
94 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products